Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients

European Journal of Medical Research

Volumn 14, Issue 8, 2009, Pages 359-363

  Bolke E ^a   Orth, K ^b   Gerber, P A ^a   Lammering, G ^c   Mota, R ^a   Peiper, M ^a   Matuschek, C ^a   Budach, W ^a   Rusnak, E ^d   Shaikh, S ^e   Dogan, B ^a   Prisack, H B ^a   Bojar, Hans ^a,f  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b KH Emden ^*  (Germany)

^c MAASTRO CLINIC   (Netherlands)

^d UNIVERSITY AT BUFFALO   (United States)

^e UMASS MEMORIAL MEDICAL CENTER   (United States)

^f NONE   (Germany)

Author keywords

Gene signature; Mamma carcinoma; Real ; Time PCR

Indexed keywords

CA 15-3 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; MAMMAGLOBIN; MUCIN 1;

ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CONTROL GROUP; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; IMMUNOMAGNETIC SEPARATION; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR GENE;

EID: 69249199624     PISSN: 09492321     EISSN: None     Source Type: Journal    
DOI: 10.1186/2047-783x-14-8-359     Document Type: Article

References (24)

1. Wang L, Wang Y, Liu Y, Cheng M, Wu X, Wei H. Flow cytometric analysis of CK19 expression in the peripheral blood of breast carcinoma patients: relevance for circulating tumor cell detection. J Exp Clin Cancer Res. 2009; 28(1): 57.
2. Cristofanilli M, Hayes DF, Budd GT, et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol. 2005; 23: 1420-1430 (Pubitemid 46260029)
3. Ashworth, T.R., A Case of Cancer in which cells similar to those in the tumors were seen in the blood after death. Australian Medical Journal. 1869; 146-148.
4. Sandberg, A.A. and G.E. Moore, Examination of blood for tumor cells. J Natl Cancer Inst, 1957; 19(1): 1-11.
5. Hsieh HB, Marrinucci D, Bethel K, et al. High speed detection of circulating tumor cells. Biosens Bioelectron 2006; 21: 1893-1899
6. Berois N., et al., Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res. 1997. 17(4A): 2639-2646
7. Hardingham, J.E., et al., Molecular detection of bloodborne epithelial cells in colorectal cancer patients and in patients with benign bowel disease. Int J Cancer. 2000. 89(1): 8-13.
8. Siegel PM, Dankort DL, Hardy WR, Muller WJ. Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol. 1994; 14: 7068-7077
9. Oh JJ, Grosshans DR, Wong SG, Slamon DJ. Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. Nucleic Acids Res. 1999; 27: 4008-4017
10. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. Embo J. 1999; 18: 2149-2164
11. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem. 1990; 265: 15286-15293 (Pubitemid 20296236)
12. Eltahir EM, Mallinson DS, Birnie GD, Hagan C, George WD, Purushotham AD. Putative markers for the detection of breast carcinoma cells in blood. Br J Cancer. 1998; 77: 1203-1207 (Pubitemid 28140606)
13. Lambrechts AC, van 't Veer LJ, Rodenhuis S. The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: use, limitations and future of RNA-based methods. Ann Oncol. 1998; 9: 1269-1276
14. Pectasides D, Pavlidis N, Gogou L, Antoniou F, Nicolaides C, Tsikalakis D. Clinical value of Ca 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients. Am J Clin Oncol. 1996; 19(5): 459-464 (Pubitemid 26314875)
15. Park BW, Oh JW, Kim JH, Park SH, Kim KS, Kim JH, Lee KS. Preoperative Ca 15-3 and CEA serum levels as predictor for breast cancer outcomes. Ann Oncol. 2008;19(4):675-681
16. Greene FL PD, Fleming ID, et al. . AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
17. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003; 100(7): 3983-3988 (Pubitemid 36418143)
18. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA, Dick JE. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994; 367(6464): 645-648 (Pubitemid 24067706)
19. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414(6859): 105-111
20. Khodarev NN, Pitroda SP, Beckett MA, MacDermed DM, Huang L, Kufe DW, Weichselbaum RR. MUC1-induced transcriptional programs associated with tumorige- nesis predict outcome in breast and lung cancer. Cancer Res. 2009; 69(7): 2833-2837 Epub 2009 Mar 24.
21. Bölke E, Peiper M, Budach W, Matuschek C, Schwarz A, Orth K, Gripp S. (2007) Unilateral keloid formation after bilateral breast surgery and unilateral radiation Eur J Med Res. 12: 320-322
22. Matthaei H, Boelke E, Eisenberger CF, Alldinger I, Krieg A, Schmelzle M, Poremba C, Schellhammer F, Knoefel WT, Budach W, Peiper M (2008). Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery. Eur J Med Res. 4: 591-594
23. Matthaei H, Bölke E, Schmelzle M, Budach W, Orth K, Engers R, Cohnen M, Matuschek C, Gripp S, Knoefel WT, Peiper M (2008). Modern therapy of rectal carcinoma. Eur J Med Res. 13: 139-146
24. Peiper M, Bölke E, Orth K, Hosch SB, Rehders A, Matthaei A, Knoefel WT (2007) Current status of radical systematic lymphadenectomy in pancreatic cancer review of the literature Eur J Med Res. 12: 1-7